You need cookies enabled

HEFCE closed at the end of March 2018. The information on this website is historical and is no longer maintained.

Many of HEFCE's functions will be continued by the Office for Students, the new regulator of higher education in England, and Research England, the new council within UK Research and Innovation.

The HEFCE domain - www.hefce.ac.uk - will continue to function until September 2018. At this point we will close the site entirely and all its information will only be available from the National Web Archive.

Cookies

You need cookies enabled

The Centre will promote the translation of these discoveries into clinical and commercial applications by providing the infrastructure required for new academic-industrial partnerships. This will have both immediate and long-term benefits for human health and the UK economy.

The Centre will house:

  • a dedicated 'Incubator' space, where research scientists from industrial partners and start-up companies will occupy laboratory and desk space alongside academic researchers
  • the Centre for Protein Misfolding Disease, which aims to effect a step-change in basic and translational research on molecular approaches to combat modern pandemics such as Alzheimer’s and Parkinson’s diseases and type II diabetes
  • the Molecular Production and Characterisation Centre, which will provide support and access to state-of-the-art instrumentation for in-house, UK-wide academic and industrial users in the chemistry of health area.

Page last updated 14 April 2015